Lichen planus pemphigoides (LPP) is a very rare autoimmune sub-epidermal blistering
disease associated with lichenoid skin changes. Initially thought to be a mere variant of …

Despite being one of the most common oral mucosal diseases and recognized as early as
1866, oral lichen planus (OLP) is still a disease without a clear etiology or pathogenesis …

Immune checkpoint inhibitors are increasingly being used in the treatment of various solid
organ and hematologic malignancies. Dermatologic toxicities associated with programmed …

Lichen planus pemphigoides (LPP) and bullous lichen planus (BLP) are rare dermatoses,
which are characterised by blisters and lichenoid lesions. Their clinical presentation is …

The oral mucosa originates in large part from an invagination of the ectoderm and is
therefore comparable with the skin. Both structures are composed of highly specialized …

Immune-related disorders of the oral cavity may occur as primary disease process,
secondary to systemic disease or neoplasm, or as a reaction to medications and other …

Zusammenfassung Der Lichen ruber, auch Lichen ruber planus oder Lichen planus (LP)
genannt, ist eine nichtkontagiöse Hauterkrankung entzündlicher Genese. Er ist der …

Toripalimab and pembrolizumab belong to anti-programmed death receptor-1 monoclonal
antibodies for the treatment of various cancers. Anti-programmed death receptor-1 therapy …

Lichen planus pemphigoides (LPP) is a rare autoimmune subepidermal disease that can
occur in patients receiving immune checkpoint inhibitors. Its clinical manifestations are …

Background/purpose Mucous membrane pemphigoid (MMP) is a rare autoimmune disease
affecting mucous membrane of the body. Oral involvement is common causing chronic and …